Paraoxonases-1, -2 and -3: What are their functions?
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Paraoxonase-1 (PON1), an esterase/lactonase primarily associated with plasma high-density lipoprotein (HDL), was the first member of this family of enzymes to be characterized. Its name was derived from its ability to hydrolyze paraoxon, the toxic metabolite of the insecticide parathion. Related enzymes PON2 and PON3 were named from their evolutionary relationship with PON1. Mice with each PON gene knocked out were generated at UCLA and have been key for elucidating their roles in organophosphorus (OP) metabolism, cardiovascular disease, innate immunity, obesity, and cancer. PON1 status, determined with two-substrate analyses, reveals an individual’s functional Q192R genotype and activity levels. The three-dimensional structure for a chimeric PON1 has been useful for understanding the structural properties of PON1 and for engineering PON1 as a catalytic scavenger of OP compounds. All three PONs hydrolyze microbial N-acyl homoserine lactone quorum sensing factors, quenching Pseudomonas aeruginosa’s pathogenesis. All three PONs modulate oxidative stress and inflammation. PON2 is localized in the mitochondria and endoplasmic reticulum. PON2 has potent antioxidant properties and is found at 3- to 4-fold higher levels in females than males, providing increased protection against oxidative stress, as observed in primary cultures of neurons and astrocytes from female mice compared with male mice. The higher levels of PON2 in females may explain the lower frequency of neurological and cardiovascular diseases in females and the ability to identify males but not females with Parkinson’s disease using a special PON1 status assay. Less is known about PON3; however, recent experiments with PON3 knockout mice show them to be susceptible to obesity, gallstone formation and atherosclerosis. Like PONs 1 and 2, PON3 also appears to modulate oxidative stress. It is localized in the endoplasmic reticulum, mitochondria and on HDL. Both PON2 and PON3 are upregulated in cancer, favoring tumor progression through mitochondrial protection against oxidative stress and apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078 · cited 3×
“The question of the consequences of low PON1 levels was addressed with PON1 knockout mice (PON1−/−) mice generated by Shih, Lusis and colleagues at UCLA [33].”
BackgroundMethodSelf-citationParaoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977 · cited 8×
“The HDLs measured in patients with autoimmune disease with and without subclinical atherosclerosis were separated by ultracentrifugation, and presence of PON3 in LDLs was not studied [139].”
BackgroundInfluentialAldridge, W. N. (1953) · Biochemical Journal · doi:10.1042/bj0530110 · Cited by 842 · cited 2×
“Aldridge had classified organophosphate (OP) hydrolases as either A- or B-esterases, based on whether they catalytically hydrolyzed OP compounds (A esterases) or were irreversibly inhibited by binding an OP compound (B esterases) [1].”
BackgroundThe molecular basis of the human serum paraoxonase activity polymorphism
Humbert, R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J., & Furlong, C. E. (1993) · Nature Genetics · doi:10.1038/ng0193-73 · Cited by 841 · cited 3×
“The latter was subsequently shown to determine the catalytic efficiency of hydrolysis of PO [17, 18].”
BackgroundMethodSelf-citationThe effects of hormones on sex differences in infection: from genes to behavior
Klein, S. L. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00027-0 · Cited by 841
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818 · cited 1×
“activity measurements in epidemiological studies that examine the relationship of PON1 genetic variability to risk of disease or exposure [26, 44].”
BackgroundDraganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R., & La Du, B. N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400511-jlr200 · Cited by 715 · cited 2×
“PON2 does not have the OP-hydrolyzing activities of PON1, but as the other two PONs, it is a lactonase, displaying overlapping but distinct substrate specificities for lactone hydrolysis [73].”
BackgroundThe role of pyocyanin in Pseudomonas aeruginosa infection
Lau, G. W., Hassett, D. J., Ran, H., & Kong, F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.10.002 · Cited by 688
The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family
Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., & Du, B. N. L. (1996) · Genomics · doi:10.1006/geno.1996.0225 · Cited by 673 · cited 5×
“PON3 was the last member of the PON family of proteins to be described [2] and is the least characterized.”
BackgroundInfluentialHarel, M., Aharoni, A., Gaidukov, L., Brumshtein, B., Khersonsky, O., Meged, R., Dvir, H., Ravelli, R. B. G., McCarthy, A., Toker, L., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb767 · Cited by 646 · cited 1×
“be crystallized to provide a tentative 3D structure of PON1, a six-bladed beta-sheet propeller structure [37].”
BackgroundThe effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
Davies, H. G., Richter, R. J., Keifer, M., Broomfield, C. A., Sowalla, J., & Furlong, C. E. (1996) · Nature Genetics · doi:10.1038/ng1196-334 · Cited by 603 · cited 1×
“The Q192R polymorphism did not significantly affect the catalytic efficiency for hydrolysis of phenyl acetate (arylesterase activity – AREase) or diazoxon (DZO) but did affect the catalytic efficiency of PO, chlorpyrifos oxon (CPO) [19] and the nerve agents sarin and soman [20].”
BackgroundSelf-citationBesler, C., Heinrich, K., Rohrer, L., Doerries, C., Riwanto, M., Shih, D. M., Chroni, A., Yonekawa, K., Stein, S., Schaefer, N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42946 · Cited by 535 · cited 1×
“[45] which shows high PON1 activity in healthy individuals, but low activity in individuals with CVD, data consistent with other studies by Camps, Joven and colleagues [46–50].”
ResultSelf-citationPharmacogenetics of paraoxonases: a brief review
Draganov, D. I., & Du, B. N. L. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0833-1 · Cited by 489 · cited 7×
“Like PON2, PON3 cannot hydrolyze OPs [72], but it retains lipo-lactonase and N-acyl homoserine lactone activities.”
BackgroundInfluentialModulation of paraoxonase (PON1) activity
Costa, L. G., Vitalone, A., Cole, T. B., & Furlong, C. E. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.08.027 · Cited by 488
Self-citationAdkins, S., Gan, K., Mody, M., & Du, B. N. L. (1993) · PubMed · Cited by 478
Ng, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S., Grijalva, V. R., Navab, M., Fogelman, A. M., & Reddy, S. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105660200 · Cited by 466 · cited 4×
“In several tissues, PON2 has been shown to exhibit antioxidant properties [65].”
BackgroundResultInfluentialParaoxonase-1 is a major determinant of clopidogrel efficacy
Bouman, H. J., Schömig, E., van Werkum, J. W., Velder, J., Hackeng, C. M., Hirschhäuser, C., Waldmann, C., Schmalz, H.-G., ten Berg, J. M., & Taubert, D. (2011) · Nature Medicine · doi:10.1038/nm.2281 · Cited by 465
Structure−Reactivity Studies of Serum Paraoxonase PON1 Suggest that Its Native Activity Is Lactonase
Khersonsky, O., & Tawfik, D. S. (2005) · Biochemistry · doi:10.1021/bi047440d · Cited by 456
Aldridge, W. N. (1953) · Biochemical Journal · doi:10.1042/bj0530117 · Cited by 446 · cited 1×
“In a second publication, Aldridge noted that the rabbit had the highest serum A-esterase of the species examined and the ratio of the serum to liver activity was very high while the opposite was true in rat [6].”
BackgroundHuman Serum Paraoxonase (pon1) Isozymes Q and R Hydrolyze Lactones and Cyclic Carbonate Esters
Billecke, S., Draganov, D., Counsell, R., Stetson, P., Watson, C., Hsu, C., & Du, B. N. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15082-9 · Cited by 402 · cited 3×
“However, the reported low substrate affinity and very low specific activity for hydrolysis of HCTL by PON1 [57, 59] have raised doubts about the physiological relevance of this activity [10, 60].”
BackgroundCalcium-dependent Human Serum Homocysteine Thiolactone Hydrolase
Jakubowski, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3957 · Cited by 398 · cited 3×
“The earlier proposals that the thiolactonase activity of PON1 is important for detoxifying homocysteine thiolactone [57] and bioactivating clopidogrel [152] do not make sense in light of the much higher activity of biphenyl hydrolase-like protein in the case of homocysteine thiolactone [61] and the role of the cytochr…”
BackgroundReddy, S. T., Wadleigh, D. J., Grijalva, V., Ng, C., Hama, S., Gangopadhyay, A., Shih, D. M., Lusis, A. J., Navab, M., & Fogelman, A. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.542 · Cited by 370
Effects of 5′ Regulatory-Region Polymorphisms on Paraoxonase-Gene (PON1) Expression
Brophy, V. H., Jampsa, R. L., Clendenning, J. B., McKinstry, L. A., Jarvik, G. P., & Furlong, C. E. (2001) · The American Journal of Human Genetics · doi:10.1086/320600 · Cited by 368 · cited 2×
“We developed two approaches for examining PON1 genetic variability; 1) protocols for characterizing PON1 SNVs [17, 21] and 2) activity measurements with two substrates when plotted as two-dimensional plots provided both the functional position 192 genotype as well as the activity levels of PON1.”
MethodSelf-citationDraganov, D. I., Stetson, P. L., Watson, C. E., Billecke, S. S., & La Du, B. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004543200 · Cited by 338
Jarvik, G. P., Rozek, L. S., Brophy, V. H., Hatsukami, T. S., Richter, R. J., Schellenberg, G. D., & Furlong, C. E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2441 · Cited by 309 · cited 1×
“An example of this analysis applied to a study of PON1 variability and carotid artery disease is shown in Figure 2 [43].”
MethodSelf-citationThe paraoxonase gene family and atherosclerosis
Ng, C. J., Shih, D. M., Hama, S. Y., Villa, N., Navab, M., & Reddy, S. T. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.035 · Cited by 292
Determination of paraoxonase (PON1) status requires more than genotyping
Richter, R. J., & Furlong, C. E. (1999) · Pharmacogenetics · doi:10.1097/00008571-199912000-00009 · Cited by 281
Self-citationLi, W.-F., Costa, L. G., Richter, R. J., Hagen, T., Shih, D. M., Tward, A., Lusis, A. J., & Furlong, C. E. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00002 · Cited by 276 · cited 15×
“The PON1−/− mice also provided a model system for testing under physiological conditions the efficacy of purified [19] and recombinant engineered human PON1 [8] to protect against OP exposure when injected into the PON1−/− mice.”
BackgroundSelf-citationDeakin, S., Leviev, I., Gomaraschi, M., Calabresi, L., Franceschini, G., & James, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107440200 · Cited by 251 · cited 1×
“Earlier results showing the transfer of PON1 between membranes [4] and the localization of PON1 in multiple mouse tissues [5] suggested that PON1 is transferred via HDLs from the liver to tissues where its activity is needed.”
BackgroundHorke, S., Witte, I., Wilgenbus, P., Krüger, M., Strand, D., & Förstermann, U. (2007) · Circulation · doi:10.1161/circulationaha.106.681700 · Cited by 246 · cited 4×
“PON2 antagonizes oxidative stress generated by various sources in the intestine of humans and rats [68], in human vascular endothelial cells [71], in lung epithelial carcinoma cells [76], in Caco-2/15 intestinal epithelial cells [83], and in mouse macrophages [67].”
BackgroundResultInfluentialSurmeier, D. J., Guzman, J. N., Sanchez-Padilla, J., & Schumacker, P. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.045 · Cited by 236
Cytoplasmic Rbfox1 Regulates the Expression of Synaptic and Autism-Related Genes
Lee, J.-A., Damianov, A., Lin, C.-H., Fontes, M., Parikshak, N. N., Anderson, E. S., Geschwind, D. H., Black, D. L., & Martin, K. C. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.025 · Cited by 232
Furlong, C. E., Richter, R. J., Seidel, S. L., Costa, L. G., & Motulsky, A. G. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90424-7 · Cited by 230 · cited 2×
“Experiments with PON1K192 showed that this engineered PON1 variant provided good protection against DZO exposure when injected pre- or post-exposure and was able to provide protection for at least 48 h post-injection [8].”
MethodSelf-citationHuman and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing
Ozer, E. A., Pezzulo, A., Shih, D. M., Chun, C., Furlong, C., Lusis, A. J., Greenberg, E. P., & Zabner, J. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.09.023 · Cited by 226 · cited 1×
“Quorum sensing—All three PONs inactivate the Pseudomonas quorum sensing factor N(3-oxododecanoyl)-L-homoserine lactone (3OC12-HSL) [51].”
BackgroundSelf-citationActions of estrogens on glial cells: Implications for neuroprotection
Arevalo, M.-A., Santos-Galindo, M., Bellini, M.-J., Azcoitia, I., & Garcia-Segura, L. M. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.10.002 · Cited by 214
Steroids as Immunosuppressants in Pregnancy
Stites, D. P., & Siiteri, P. K. (1983) · Immunological Reviews · doi:10.1111/j.1600-065x.1983.tb01093.x · Cited by 208
Pseudomonas Pyocyanin Increases Interleukin-8 Expression by Human Airway Epithelial Cells
Denning, G. M., Wollenweber, L. A., Railsback, M. A., Cox, C. D., Stoll, L. L., & Britigan, B. E. (1998) · Infection and Immunity · doi:10.1128/iai.66.12.5777-5784.1998 · Cited by 206
Mitochondrial mechanisms of estrogen neuroprotection
Simpkins, J. W., Yi, K. D., Yang, S.-H., & Dykens, J. A. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.11.013 · Cited by 203
Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues
Marsillach, J., Mackness, B., Mackness, M., Riu, F., Beltrán, R., Joven, J., & Camps, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.023 · Cited by 196 · cited 4×
“This observation was supported by immunohistochemical analysis of PON3 expression in normal mouse tissues [5] and by Pon3 mRNA expression via in situ hybridization [143].”
BackgroundResultSelf-citationHomocysteine Is a Protein Amino Acid in Humans
Jakubowski, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200267200 · Cited by 190
Costa, L. G., Giordano, G., & Furlong, C. E. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.008 · Cited by 189
Self-citationDevarajan, A., Bourquard, N., Hama, S., Navab, M., Grijalva, V. R., Morvardi, S., Clarke, C. F., Vergnes, L., Reue, K., Teiber, J. F., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3430 · Cited by 185
Mochizuki, H., Scherer, S. W., Xi, T., Nickle, D. C., Majer, M., Huizenga, J. J., Tsui, L.-C., & Prochazka, M. (1998) · Gene · doi:10.1016/s0378-1119(98)00193-0 · Cited by 180 · cited 3×
“PON2 mRNA has also been found in mouse and human brain [2, 64, 65, 92], and PON2 protein has been detected in mouse [5, 85] and monkey brain [93].”
BackgroundResultSuehiro, T., Nakamura, T., Inoue, M., Shiinoki, T., Ikeda, Y., Kumon, Y., Shindo, M., Tanaka, H., & Hashimoto, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00379-2 · Cited by 172
Serum paraoxonase status: A major factor in determining resistance to organophosphates
Li, W., Costa, L. G., & Furlong, C. E. (1993) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399309531798 · Cited by 167 · cited 2×
“Experiments with rats [30] and mice [31, 32] extended Main’s initial observations to include both PO and CPO.”
BackgroundMethodSelf-citationRosenblat, M., Draganov, D., Watson, C. E., Bisgaier, C. L., La Du, B. N., & Aviram, M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000059385.95664.4d · Cited by 167 · cited 4×
“PON2 antagonizes oxidative stress generated by various sources in the intestine of humans and rats [68], in human vascular endothelial cells [71], in lung epithelial carcinoma cells [76], in Caco-2/15 intestinal epithelial cells [83], and in mouse macrophages [67].”
BackgroundInfluentialNg, C. J., Bourquard, N., Grijalva, V., Hama, S., Shih, D. M., Navab, M., Fogelman, A. M., Lusis, A. J., Young, S., & Reddy, S. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605379200 · Cited by 165 · cited 4×
“The question of the consequences of low PON1 levels was addressed with PON1 knockout mice (PON1−/−) mice generated by Shih, Lusis and colleagues at UCLA [33].”
BackgroundInfluentialAltenhöfer, S., Witte, I., Teiber, J. F., Wilgenbus, P., Pautz, A., Li, H., Daiber, A., Witan, H., Clement, A. M., Förstermann, U., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118604 · Cited by 161
Paraoxonase-2 deficiency enhancesPseudomonas aeruginosaquorum sensing in murine tracheal epithelia
Stoltz, D. A., Ozer, E. A., Ng, C. J., Yu, J. M., Reddy, S. T., Lusis, A. J., Bourquard, N., Parsek, M. R., Zabner, J., & Shih, D. M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00370.2006 · Cited by 161
Of Mice and Women: The Bias in Animal Models
Wald, C., & Wu, C. (2010) · Science · doi:10.1126/science.327.5973.1571 · Cited by 159
Teiber, J. F., Horke, S., Haines, D. C., Chowdhary, P. K., Xiao, J., Kramer, G. L., Haley, R. W., & Draganov, D. I. (2008) · Infection and Immunity · doi:10.1128/iai.01606-07 · Cited by 159
Oxidative Stress: Emerging Mitochondrial and Cellular Themes and Variations in Neuronal Injury
Higgins, G. C., Beart, P. M., Shin, Y. S., Chen, M. J., Cheung, N. S., & Nagley, P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100321 · Cited by 156 · cited 1×
“Mitochondria are a major source of free radical-related oxidative stress [88], and the preponderant localization of PON2 in mitochondria would support a role for this enzyme in protecting cells from oxidative damage.”
BackgroundAutoantibodies Against N -Homocysteinylated Proteins in Humans: Implications for Atherosclerosis
Undas, A., Perła‐Kaján, J., Łaciński, M., Trzeciak, W. H., Kaźmierski, R., & Jakubowski, H. (2004) · Stroke · doi:10.1161/01.str.0000128412.59768.6e · Cited by 156
Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3
Teiber, J. F., Draganov, D. I., & Du, B. N. L. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00401-5 · Cited by 153
Implications of gender differences for human health risk assessment and toxicology
Vahter, M., Gochfeld, M., Casati, B., Thiruchelvam, M. J., Filipsson, A. F., Kavlock, R. J., MARAFANTE, E., & Cory‐Slechta, D. A. (2006) · Environmental Research · doi:10.1016/j.envres.2006.10.001 · Cited by 132
Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate Substrates
Richter, R. J., Jarvik, G. P., & Furlong, C. E. (2008) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.811638 · Cited by 127
Self-citationShiner, M., Fuhrman, B., & Aviram, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.01.007 · Cited by 124
Chen, Q., Reís, S. E., Kammerer, C. M., McNamara, D. M., Holubkov, R., Sharaf, B. L., Sopko, G. S., Pauly, D. F., Merz, C. N. B., & Kamboh, M. I. (2003) · The American Journal of Human Genetics · doi:10.1086/345312 · Cited by 121
Dansette, P. M., Rosi, J., Bertho, G., & Mansuy, D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx2004085 · Cited by 120
Giordano, G., Tait, L., Furlong, C. E., Cole, T. B., Kavanagh, T. J., & Costa, L. G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.019 · Cited by 112 · cited 7×
“In a series of recent studies, the protein expression of PON2 has been characterized in mouse brain [66, 94, 95].”
BackgroundSelf-citationFerré, N., Marsillach, J., Camps, J., Mackness, B., Mackness, M., Riu, F., Coll, B., Tous, M., & Joven, J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.018 · Cited by 103
Self-citationBeyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells
Witte, I., Altenhöfer, S., Wilgenbus, P., Amort, J., Clement, A. M., Pautz, A., Li, H., Förstermann, U., & Horke, S. (2011) · Cell Death and Disease · doi:10.1038/cddis.2010.91 · Cited by 103 · cited 2×
“A caveat to this strategy is represented by the findings that in tumor cells PON2 is up-regulated, by still unknown mechanisms [97].”
BackgroundThe Female Advantage in Cardiovascular Disease: Do Vascular Beds Contribute Equally?
Kardys, I., Vliegenthart, R., Oudkerk, M., Hofman, A., & Witteman, J. C. M. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm115 · Cited by 100
Polymorphisms in the PON gene cluster are associated with Alzheimer disease
Erlich, P. M., Lunetta, K. L., Cupples, L. A., Huyck, M., Green, R. C., Baldwin, C. T., & Farrer, L. A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi428 · Cited by 99
Tougou, K., Nakamura, A., Watanabe, S., Okuyama, Y., & MORINO, A. (1998) · PubMed · Cited by 99
Protective Mechanisms against Homocysteine Toxicity
Zimny, J., Sikora, M., Guranowski, A., & Jakubowski, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603656200 · Cited by 99
Decreased Obesity and Atherosclerosis in Human Paraoxonase 3 Transgenic Mice
Shih, D. M., Xia, Y.-R., Wang, X.-P., Wang, S. S., Bourquard, N., Fogelman, A. M., Lusis, A. J., & Reddy, S. T. (2007) · Circulation Research · doi:10.1161/01.res.0000264499.48737.69 · Cited by 98
Evolved Stereoselective Hydrolases for Broad-Spectrum G-Type Nerve Agent Detoxification
Goldsmith, M., Ashani, Y., Simo, Y., Ben-David, M., Leader, H., Silman, I., Sussman, J. L., & Tawfik, D. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.017 · Cited by 97
The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism
Mackness, B. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6561-3 · Cited by 96
Paraoxonase 2 (PON2) in the mouse central nervous system: A neuroprotective role?
Giordano, G., Cole, T. B., Furlong, C. E., & Costa, L. G. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.02.014 · Cited by 92 · cited 10×
“In a series of recent studies, the protein expression of PON2 has been characterized in mouse brain [66, 94, 95].”
BackgroundMethodResultSelf-citationStoltz, D. A., Ozer, E. A., Taft, P. J., Barry, M., Liu, L., Kiss, P. J., Moninger, T. O., Parsek, M. R., & Zabner, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35147 · Cited by 91 · cited 1×
“An elegant experiment carried out by Stoltz and colleagues at the University of Iowa demonstrated that a transgenic Drosophila melanogaster expressing human tgHuPON1 was resistant to the lethality of infection by Pseudomonas aeruginosa as well as resistant to CPS exposure [52].”
BackgroundSchweikert, E.-M., Devarajan, A., Witte, I., Wilgenbus, P., Amort, J., Förstermann, U., Shabazian, A., Grijalva, V. R., Shih, D. M., Farias‐Eisner, R., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.35 · Cited by 89
Levy, E. H., Trudel, K., Bendayan, M., Seidman, E. G., DELVIN, E. E., Elchebly, M., Lavoie, J., Précourt, L., Amre, D. K., & Sinnett, D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00369.2007 · Cited by 86 · cited 3×
“In the gastrointestinal tract, PON2 antagonizes oxidative and inflammatory processes that may affect mucosal integrity [68].”
BackgroundResultNg, C. J., Hama, S. Y., Bourquard, N., Navab, M., & Reddy, S. T. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.07.004 · Cited by 84 · cited 2×
“These antioxidant effects of PON2 are believed to play a major role in preventing the atherosclerotic process, as shown by studies indicating that PON2 over-expression decreases atherosclerotic lesions, while the opposite is true in PON2-null (PON2−/−) mice [84, 85].”
BackgroundParra, S., Alonso‐Villaverde, C., Coll, B., Ferré, N., Marsillach, J., Aragonès, G., Mackness, M., Mackness, B., Masana, L., Joven, J., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.024 · Cited by 78
Self-citationShiner, M., Fuhrman, B., & Aviram, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.003 · Cited by 78
Role of astroglia in the neuroplastic and neuroprotective actions of estradiol
Azcoitia, Í., Santos‐Galindo, M., Arévalo, M., & García‐Segura, L. M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07516.x · Cited by 78
Nishimuta, H., Houston, J. B., & Galetin, A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057372 · Cited by 77
Female Adult Mouse Cardiomyocytes Are Protected Against Oxidative Stress
Wang, F., He, Q., Sun, Y., Dai, X., & Yang, X.-P. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.150839 · Cited by 76
Liu, M., Liao, Y., Lin, R., Wang, Y., Hsi, E., Lin, H., Chen, K., & Juo, S. H. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.036 · Cited by 75 · cited 1×
“An interesting report noted that a 3′ UTR SNV (CT at rs3735590) affected binding of a miRNA (miR-616) to the 3′ UTR of PON1 mRNA with the T allele having lower binding affinity, causing higher levels of expression of PON1 and reducing the risk of ischemic stroke and carotid atherosclerosis in individuals with the CT o…”
BackgroundBoesch, C., Pospissil, R. T., Graeser, A.-C., Canali, R., Boomgaarden, I., Doering, F., Wolffram, S., Egert, S., Mueller, M. J., & Rimbach, G. H. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10094168 · Cited by 73
Estrogen and the regulation of mitochondrial structure and function in the brain
Arnold, S., Victor, M. B., & Beyer, C. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.01.012 · Cited by 70
A Common Mutation in Paraoxonase-2 Results in Impaired Lactonase Activity
Stoltz, D. A., Ozer, E. A., Recker, T. J., Estin, M. L., Yang, X., Shih, D. M., Lusis, A. J., & Zabner, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051706 · Cited by 70 · cited 3×
“The PON2 S311C SNV has been shown to affect lactonase activity [77].”
BackgroundRothem, L., Hartman, C., Dahan, A., Lachter, J., Eliakim, R., & Shamir, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.003 · Cited by 69
Horke, S., Witte, I., Wilgenbus, P., Altenhöfer, S., Krüger, M., Li, H., & Förstermann, U. (2008) · Biochemical Journal · doi:10.1042/bj20080775 · Cited by 68
Rosenblat, M., Hayek, T., Hussein, K., & Aviram, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000104011.88939.06 · Cited by 66
Structural Organization of the HumanPON1Gene
Clendenning, J. B., Humbert, R., Green, E. D., Wood, C. M., Traver, D. J., & Furlong, C. E. (1996) · Genomics · doi:10.1006/geno.1996.0401 · Cited by 63
Self-citationMarsillach, J., Becker, J. O., Vaisar, T., Hahn, B. H., Brunzell, J. D., Furlong, C. E., de Boer, I. H., McMahon, M. A., Hoofnagle, A. N., & DCCT/EDIC Research Group (2015) · Journal of Proteome Research · doi:10.1021/pr5011586 · Cited by 63
Self-citationCosta, L. G., Tait, L., de Laat, R., Dao, K., Giordano, G., Pellacani, C., Cole, T. B., & Furlong, C. E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1085-1 · Cited by 62 · cited 4×
“Even though dopaminergic areas (striatum, substantia nigra, and nucleus accumbens) have the highest levels of PON2 in both genders, levels in females are still 2- to 3-fold higher than in males [66, 94, 95].”
BackgroundSelf-citationRosenblat, M., Coleman, R., Reddy, S. T., & Aviram, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800550-jlr200 · Cited by 62 · cited 1×
“In macrophages, PON2 has been suggested to protect against accumulation of triglycerides and oxidative stress, thereby attenuating the development of vascular complications in diabetes [86, 87].”
BackgroundNg, C. J., Bourquard, N., Hama, S. Y., Shih, D. M., Grijalva, V. R., Navab, M., Fogelman, A. M., & Reddy, S. T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.134189 · Cited by 60
Horke, S., Witte, I., Altenhöfer, S., Wilgenbus, P., Goldeck, M., Förstermann, U., Xiao, J., Kramer, G. L., Haines, D. C., Chowdhary, P. K., et al. (2009) · Biochemical Journal · doi:10.1042/bj20091414 · Cited by 60 · cited 3×
“PON2 antagonizes oxidative stress generated by various sources in the intestine of humans and rats [68], in human vascular endothelial cells [71], in lung epithelial carcinoma cells [76], in Caco-2/15 intestinal epithelial cells [83], and in mouse macrophages [67].”
BackgroundResultWorek, F., Seeger, T., Goldsmith, M., Ashani, Y., Leader, H., Sussman, J. L., Tawfik, D. S., Thiermann, H., & Wille, T. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1204-z · Cited by 59
Ferré, N., Feliu, A., García‐Heredia, A., Marsillach, J., Miró, N. P., Zaragoza-Jordana, M., Mackness, B., Mackness, M., Escribano, J., Closa‐Monasterolo, R., et al. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.08.020 · Cited by 57
Self-citationYang, Y., Zhang, Y., Cuevas, S., Villar, V. A. M., Escano, C. S., Asico, L. D., Yu, P., Grandy, D. K., Felder, R. A., Armando, I., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.015 · Cited by 56
PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis
Shih, D. M., Yu, J. M., Vergnes, L., Dali‐Youcef, N., Champion, M. D., Devarajan, A., Zhang, P., Castellani, L. W., Brindley, D. N., Jamey, C., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-260570 · Cited by 54
Same sex, no sex, and unaware sex in neurotoxicology
Weiss, B. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2010.09.005 · Cited by 53
Fernandes, E. S., Machado, M. D. O., Becker, A. M., de Andrade, F., Maraschin, M., & da Silva, E. L. (2012) · Nutrition · doi:10.1016/j.nut.2012.04.011 · Cited by 49
Shi, J., Zhang, S., Tang, M., Liu, X., Li, T., Han, H., Wang, Y., Guo, Y., Zhao, J., Li, H., et al. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.10.018 · Cited by 44
Fuhrman, B., Gantman, A., Khateeb, J., Volkova, N., Horke, S., Kiyan, Y., Dumler, I., & Aviram, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp184 · Cited by 43
Effect of N‐homocysteinylation on physicochemical and cytotoxic properties of amyloid β‐peptide
Khodadadi, S., Riazi, G. H., Ahmadian, S., Hoveizi, E., Karima, O., & Aryapour, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.12.018 · Cited by 43
Leviev, I., Kalix, B., Meynet, M.-C. B., & James, R. W. (2001) · Diabetologia · doi:10.1007/s001250100610 · Cited by 43
Novel Roflumilast analogs as soft PDE4 inhibitors
Boland, S., Alen, J., Bourin, A., Castermans, K., Boumans, N., Panitti, L., Vanormelingen, J., Leysen, D. C., & Defert, O. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.016 · Cited by 42
Precourt, L.-P., Seidman, E., Delvin, E., Amre, D., Deslandres, C., Dominguez, M., Sinnett, D., & Levy, E. (2009) · International Journal of Biochemistry and Cell Biology · doi:10.1016/j.biocel.2009.02.013 · Cited by 39 · cited 2×
“PON2 antagonizes oxidative stress generated by various sources in the intestine of humans and rats [68], in human vascular endothelial cells [71], in lung epithelial carcinoma cells [76], in Caco-2/15 intestinal epithelial cells [83], and in mouse macrophages [67].”
BackgroundResultBourquard, N., Ng, C. J., & Reddy, S. T. (2011) · Biochemical Journal · doi:10.1042/bj20101891 · Cited by 39 · cited 1×
“The absence of PON2 in PON2−/− mice exacerbates the macrophage inflammatory response [90].”
BackgroundYehuda, I., Madar, Z., Szuchman-Sapir, A. J., & Tamir, S. (2010) · Phytotherapy Research · doi:10.1002/ptr.3318 · Cited by 39
Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity
Camps, J., Marsillach, J., & Joven, J. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788681591 · Cited by 38
Self-citationMackness, B., McElduff, P., & Mackness, M. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01554.x · Cited by 38
Meilin, E., Aviram, M., & Hayek, T. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.057 · Cited by 37 · cited 1×
“In macrophages, PON2 has been suggested to protect against accumulation of triglycerides and oxidative stress, thereby attenuating the development of vascular complications in diabetes [86, 87].”
BackgroundIdentification of paraoxonase 3 gene (PON3) missense mutations in a population of southern Italy
Campo, S., Sardo, M. A., Campo, G. M., Avenoso, A., Castaldo, M., D’Ascola, A., Giunta, E., Calatroni, A., & Saitta, A. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.11.007 · Cited by 36
Fuhrman, B., Khateeb, J., Shiner, M., Nitzan, O., Karry, R., Volkova, N., & Aviram, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.166041 · Cited by 33
Rosenblat, M., Volkova, N., Roqueta‐Rivera, M., Nakamura, M., & Aviram, M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.044 · Cited by 32
Aragonès, G., Guardiola, M., Barreda‐Sánchez, M., Marsillach, J., Beltrán‐Debón, R., Rull, A., Mackness, B., Mackness, M., Joven, J., Simó, J. M., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d014134 · Cited by 30
Self-citationKim, D. S., Crosslin, D. R., Auer, P. L., Suzuki, S. M., Marsillach, J., Burt, A., GORDON, A. S., Meschia, J. F., Nalls, M. A., Worrall, B. B., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p049247 · Cited by 29
Self-citationRull, A., García, R., Fernández-Sénder, L., García‐Heredia, A., Aragonès, G., Beltrán‐Debón, R., Marsillach, J., Alegret, J. M., Martín-Paredero, V., Mackness, B., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.021 · Cited by 28
Self-citationCole, T. B., Beyer, R. P., Bammler, T. K., Park, S. S., Farin, F. M., Costa, L. G., & Furlong, C. E. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr157 · Cited by 27 · cited 1×
“5 times more resistant to CPO exposure than the PON1−/− mice [36].”
BackgroundSelf-citationParaoxonase-1 status in patients with hereditary hemochromatosis
Martinelli, N., García‐Heredia, A., Roca, H., Aranda, N., Arija, V., Mackness, B., Mackness, M., Busti, F., Aragonès, G., Pedro‐Botet, J., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p028977 · Cited by 26
Self-citationDevelopmental expression of paraoxonase 2
Garrick, J. M., Dao, K., de Laat, R., Elsworth, J. D., Cole, T. B., Marsillach, J., Furlong, C. E., & Costa, L. G. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.04.001 · Cited by 25 · cited 2×
“First, similar gender differences were also found in rats, humans [94], and non-human primates[93].”
BackgroundSelf-citationAragonès, G., García‐Heredia, A., Guardiola, M., Rull, A., Beltrán‐Debón, R., Marsillach, J., Alonso‐Villaverde, C., Mackness, B., Mackness, M., Pedro‐Botet, J., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.p018457 · Cited by 24
Self-citationThe Functional Consequences of Polymorphisms in the Human PON1 Gene
Furlong, C. E., Richter, R. J., Li, W.-F., Brophy, V. H., Carlson, C. J., Rieder, M. J., Nickerson, D. A., Costa, L. G., Ranchalis, J., Lusis, A. J., et al. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6561-3_18 · Cited by 21 · cited 2×
“Sequencing studies in which the PON1 genes of 47 individuals (24 African-Americans and 23 Europeans) revealed 108 new PON1 polymorphisms, including 8 new promoter region SNVs, 9 additional 3′ SNVs and a new coding region SNV (W194X) [26].”
BackgroundSelf-citationGarcía‐Heredia, A., Marsillach, J., Aragonès, G., Guardiola, M., Rull, A., Beltrán‐Debón, R., Folch, A., Mackness, B., Mackness, M., Pedro‐Botet, J., et al. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.08.003 · Cited by 19
Self-citationTranscriptional activation of an anti-oxidant mouse Pon2 gene by dexamethasone
Lim, J.-A., & Kim, S. H. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.7.421 · Cited by 18
Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease
Sánchez, R., Levy, E. H., Seidman, E. G., Amre, D. K., Costea, F., & Sinnett, D. (2006) · Gut · doi:10.1136/gut.2006.107953 · Cited by 13
Li, B., Zhang, L., Yin, Y.-W., et al. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1367-0 · Cited by 12
Cited by
Jamwal, S., Blackburn, J. K., & Elsworth, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107705 · Cited by 236
Zimetti, F., Adorni, M. P., Marsillach, J., Marchi, C., Trentini, A., Valacchi, G., & Cervellati, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6695796 · Cited by 49
“However, based on the significant homology of the 3 paraoxonases, we could speculate that factors known to modulate PON1 and PON2 would likely have an effect on PON3.”
BackgroundSelf-citationSalas-Pérez, F., Cuevas-Sierra, A., Cuervo, M., Goni, L., Milagro, F. I., Martínez, J. A., & Riezu-Boj, J. I. (2022) · Epigenetics · doi:10.1080/15592294.2021.1873629 · Cited by 16
“PON1 and PON3 are known to protect LDL from oxidation [32,34].”
Background
Metadata
- Authors
- Furlong, C. E., Marsillach, J., Jarvik, G. P., & Costa, L. G.
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 259
- Issue
- Pt B
- Pages
- 51-62
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W2405907603
- Cited by
- 208
- References
- 128
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.